WA People
BILL · 2019–20 SESSION · LATEST VERSION 2SSB 5292

SB 5292: Rx drug cost transparency

Concerning prescription drug cost transparency.

Summary

  • Requires issuers and drug manufacturers to report certain prescription drug pricing data to a data organization contracted by the Health Care Authority (HCA).
  • Requires the data organization to summarize the prescription drug pricing data and provide reports to the Legislature and the HCA.
  • Requires pharmacy benefit managers (PBMs) to submit certain information on discounts, rebates, and reimbursement for drugs in a PBM's formulary.
  • Requires the Office of the Insurance Commissioner (OIC) to analyze and report on the data submitted by PBMs and allows OIC to audit a PBM's financial records to ensure the information submitted is accurate.
  • Requires manufacturers to report drug shortages to the HCA within 30 days of a drug shortage occurring.

From the Second Substitute House Bill Report (2SSB 5292), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · passed Senate, stalled in House
  1. IntroducedJan 17, 2019
  2. Out of committeeFeb 28, 2019
  3. Passed SenateFeb 28, 2019
  4. Passed Housestopped here
  5. Governor
  6. Law
Prime sponsor
Karen Keiser (D-33)
Introduced
January 17, 2019 in the Senate
Last action
January 13, 2020
Budget
Has a fiscal note
Versions
SB 5292, SSB 5292, 2SSB 5292

AN ACT Relating to prescription drug cost transparency;

Sponsors

Prime sponsor: Karen Keiser (D-33)

12 co-sponsors (12 Democrats, 0 Republicans)

Annette Cleveland D-49Emily Randall D-26Bob Hasegawa D-11Senator D-47Rebecca Saldaña D-37Claire Wilson D-30Marko Liias D-21Steve Conway D-29Patty Kuderer D-48Joe Nguyen D-34Kevin Van De Wege D-24Lisa Wellman D-41

Votes

Senate · 3rd Reading & Final Passage

Passed February 28, 2019
Version voted on: 2SSB 5292
49 Yea 0 Nay 0 Absent 0 Excused
PartyYeaNayAbsentExcused
Democrat29000
Republican20000
How each member voted

Yea (49)

Permalink to this vote

History

  1. Senate Rules "X" file. (2SSB 5292)
  2. By resolution, reintroduced and retained in present status. (2SSB 5292)
  3. By resolution, returned to Senate Rules Committee for third reading. (2SSB 5292)
  4. Referred to Appropriations. (2SSB 5292)
  5. Minority; without recommendation. (2SSB 5292)
  6. HCW - Majority; do pass with amendment(s). (2SSB 5292)
  7. First reading, referred to Health Care & Wellness. (2SSB 5292)
  8. Third reading, passed; yeas, 49; nays, 0; absent, 0; excused, 0. (2SSB 5292)
  9. Rules suspended. Placed on Third Reading. (2SSB 5292)
  10. 2nd substitute bill substituted. (2SSB 5292)
  11. Placed on second reading by Rules Committee. (2SSB 5292)
  12. Passed to Rules Committee for second reading. (2SSB 5292)
  13. Passed to Rules Committee for second reading. (SSB 5292)
  14. Placed on second reading by Rules Committee. (SSB 5292)
  15. 2nd substitute bill substituted. (SSB 5292)
  16. 2nd substitute bill substituted.
  17. Placed on second reading by Rules Committee.
  18. Passed to Rules Committee for second reading.
  19. WM - Majority; 2nd substitute bill be substituted, do pass. (2SSB 5292)
  20. WM - Majority; 2nd substitute bill be substituted, do pass. (SSB 5292)
  21. WM - Majority; 2nd substitute bill be substituted, do pass.
  22. Referred to Ways & Means. (SSB 5292)
  23. Referred to Ways & Means.
  24. HLTC - Majority; 1st substitute bill be substituted, do pass. (SSB 5292)
  25. And refer to Ways & Means. (SSB 5292)
  26. Minority; do not pass. (SSB 5292)
  27. Minority; do not pass.
  28. And refer to Ways & Means.
  29. HLTC - Majority; 1st substitute bill be substituted, do pass.
  30. First reading, referred to Health & Long Term Care.

SB 5292 in other sessions

Bill numbers restart every two years, so the same number is a different bill in each session.

Report wrong or missing information on this page